The first two studies of MIRAGE syndrome were reported by endocrinology research laboratories of Japan [5] and United Kingdom [6], and as many as 94% of the SAMD9 variant-carrying patients had adrenal insufficiency (AI) in these studies. Here, SAMD9 is linked to MIRAGE syndrome.